Brazilian Health Authorities widened the age range of potential recipients of the dengue vaccine as many doses were ...
Deadly viruses could become endemic in Europe unless urgent measures are taken, a leading expert has warned. Rising global ...
The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...
The Cool Down on MSN1d
Health officials announce outbreak of dangerous virus with major impact: 'Early diagnosis ... [is] critical'The illness typically lasts two to seven days, but severe cases can be deadly. An affected person will have flu-like symptoms ...
Three species of mosquito are of particular concern in Europe, according to the European Centre for Disease Prevention and ...
Business debate on research and innovation (R&I) funding in the EU’s new mandate, global health leaders underlined the ...
Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...
Researchers have unveiled new insights into how weather influences the spread of dengue fever. Their study identifies ...
The Pan American Health Organization (PAHO) is warning that a dengue strain, the DENV-3 serotype, is on the rise in the Caribbean which could lead to a potential increase in cases of the disease. It ...
The Pan American Health Organization (PAHO) has issued an epidemiological alert regarding the increased risk of dengue outbreaks in the Americas, attributed to the growing circulation of the DENV-3 ...
The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.
The Pan American Health Organization (PAHO) has issued an epidemiological alert regarding the increased risk of dengue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback